Use of Conversation and Acoustic Signals in Measuring Depression Severity
1 other identifier
observational
89
1 country
2
Brief Summary
The purpose of this study is to test a new monitoring technology that uses the sound of a depressed person's speech to assess the severity of depression symptoms. The Vocal Social Signals Platform (VSSP) is software that analyzes the non-verbal characteristics of a person's speech. This study will test this software to see if it could be a useful measurement tool for assessing depression symptoms. Participation in this study requires coming to the research headquarters twice over a three-month period. The first visit is to determine eligibility. Throughout the study, participants will be connected to a telephone system five times, on which they will answer questions about their depression symptoms. After answering questions, their voice will be recorded using a structured speech sample that the participant will read out loud. The participant will also give an unstructured speech sample, which will involve describing a typical day or the last movie s/he saw. The voice samples will be analyzed and compared to the results of the depression symptom questionnaires.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2009
Typical duration for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 22, 2008
CompletedStudy Start
First participant enrolled
January 1, 2009
CompletedFirst Posted
Study publicly available on registry
January 29, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2011
CompletedApril 8, 2013
April 1, 2013
2.4 years
May 22, 2008
April 5, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Inventory of Depressive Symptomatology (IDS)
3 months
Study Arms (2)
Depressed
Depressed individuals, as identified by their referring physician.
Non-depressed
Non-depressed individuals, confirmed to be non-depressed by the Centers for Epidemiological Studies Depression Scale (CES-D).
Eligibility Criteria
Community sample - residents in Boston, Massachusetts area and those referred from Boston Medical Center primary care and psychiatry departments.
You may qualify if:
- Be \> 18 years of age.
- Speak, understand and read conversational English.
- A clinical diagnosis of Major Depressive Disorder in the past 2 weeks.
You may not qualify if:
- Not having access to a telephone at home or on the person (cell phone) or at work.
- Planning to leave Boston during the study period.
- Having a long history of smoking, which is defined as 1 pack per day for 10 years or more.
- Meeting the criteria for alcohol abuse.
- Having one of the following mental illnesses based on attached instruments: Social Anxiety, Bipolar Disorder (BD) or Borderline Personality Disorder (BPD).
- Having a life threatening and/or chronic health condition such as organic brain disease, e.g., Alzheimers' Disease and other dementias, cancer, HIV or other autoimmune diseases, diabetes, heart disease, renal failure, etc.
- Having a physical condition, such as one of the following, that could affect the acoustic characteristics of speech or a condition that can alter vocal production by affecting the mouth, larynx, trachea, lungs, thorax, nose, nasal passages and sinuses, ears and hearing:
- Neurological events or diseases such as stroke, ALS, brain injury, brain tumors, Parkinson's disease, Huntington's disease and multiple sclerosis
- Chronic allergic conditions such as allergic rhinitis
- Upper or lower respiratory track infections such as sinusitis
- GERD (acid reflux)
- Anatomic abnormalities such as deviated nasal septum
- Speech impairment, as determined by the research staff
- Any other permanent, chronic or intermittent conditions that affect the quality of speech
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Boston Medical Center
Boston, Massachusetts, 02118, United States
Boston University Medical Campus
Boston, Massachusetts, 02118, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ramesh Farzanfar, Ph.D
Boston University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 22, 2008
First Posted
January 29, 2009
Study Start
January 1, 2009
Primary Completion
June 1, 2011
Study Completion
June 1, 2011
Last Updated
April 8, 2013
Record last verified: 2013-04